AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TRASTUZUMAB
62 registrations across 14 African markets— 56 active
Markets with TRASTUZUMAB
🇰🇪Kenya
9 registrations
9 active
🇿🇦South Africa
8 registrations
7 active
🌍WW
8 registrations
8 active
🇺🇬Uganda
6 registrations
6 active
🇹🇿Tanzania
6 registrations
6 active
🇹🇳Tunisia
5 registrations
0 active
🇿🇼Zimbabwe
4 registrations
4 active
🇨🇮Côte d'Ivoire
4 registrations
4 active
🇷🇼Rwanda
3 registrations
3 active
🇸🇳Senegal
3 registrations
3 active
🇲🇬Madagascar
2 registrations
2 active
🇬🇭Ghana
2 registrations
2 active
🇲🇦Morocco
1 registration
1 active
🇿🇲Zambia
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| HERCEPTIN 440MG Concentrate For Solution For Infusion | 🇰🇪Kenya | F. HOFFMAN-LA ROCHE LTD | active | Mar 2031 |
| TRASTMAB 150 Concentrate For Solution For Infusion | 🇰🇪Kenya | INTAS PHARMACEUTICALS LIMITED | active | Mar 2031 |
| TRASTMAB 440 Infusion | 🇰🇪Kenya | INTAS PHARMACEUTICALS LIMITED | active | Mar 2031 |
| Trastmab 150 LYOPHILISATE FOR CONCENTRATE FOR SOLUTION FOR INFUSION | 🇷🇼Rwanda | Intas Pharmaceutical Ltd. | active | Mar 2031 |
| SEZUMA 150 Lyophilized powder for injection | 🇷🇼Rwanda | HETERO BIOPHARMA LIMITED | active | Mar 2031 |
| SEZUMA 440 Lyophilized powder for injection | 🇷🇼Rwanda | HETERO BIOPHARMA LIMITED | active | Mar 2031 |
| Hertraz 150 infusion Lyophilised powder for injection | 🇿🇲Zambia | Biosimilars Newco Limited | active | Nov 2030 |
| Herqensa 440mg Powder For Concentrate For Solution For Infus | 🇰🇪Kenya | DR. REDDY’S LABORATORIES LIMITED | active | Apr 2030 |
| Herqensa 150MG Powder For Concentrate For Solution For Infus | 🇰🇪Kenya | DR. REDDY’S LABORATORIES LIMITED | active | Apr 2030 |
| EQUTTUZ | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Jan 2030 |
| HERCEPTIN SC 600MG/ML (TRASTUZUMAB) | 🇬🇭Ghana | — | active | Aug 2029 |
| HERCEPTIN SC 600MG/ML (TRASTUZUMAB) | 🇬🇭Ghana | — | active | Aug 2029 |
| Trastuzumab 440mg / Vial Injection | 🇰🇪Kenya | HETERO BIOPHARMA LIMITED | active | Sept 2028 |
| Trastuzumab 150mg / Vial Injection | 🇰🇪Kenya | HETERO BIOPHARMA LIMITED | active | Sept 2028 |
| KADCYLA 100MG POUDRE POUR SOLUTION A DILUER POUR PERFUSION BOITE DE 1 | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Jun 2028 |
| KADCYLA 160MG POUDRE POUR SOLUTION A DILUER POUR PERFUSION BOITE DE 1 | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Apr 2028 |
| OGIVRI POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | BIOSIMILARS NEWCO LIMITED | active | Dec 2027 |
| OGIVRI INJECTABLE; IV (INFUSION) | 🇿🇼Zimbabwe | BIOSIMILARS NEWCO LIMITED | active | Dec 2027 |
| HERCEPTIN SC INJECTABLE; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Dec 2027 |
| HERCEPTIN POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | ROCHE PRODUCTS (PTY) LTD | active | Dec 2027 |
| HERCEPTIN 150MG/5ML POUR POUR SOLUTION A DILUER POUR PERFUSION FLACON DE 15ML | 🇨🇮Côte d'Ivoire | F. HOFFMANN-LA ROCHE LTD | active | Oct 2027 |
| Herceptin SC 600mg Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd. | active | Aug 2026 |
| Herceptin SC 600mg Injection | 🇰🇪Kenya | F. Hoffmann-La Roche Ltd. | active | Aug 2026 |
| HERCLON | 🇿🇦South Africa | Roche Products (Pty) Ltd | suspended | Jul 2026 |
| HERZUMA Poudre pour solution à diluer pour perfusion / 440 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Sept 2022 |
| HERZUMA Poudre pour solution à diluer pour perfusion / 150 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Sept 2022 |
| HERTRAZ Pdre p.prep.injectable / 440 mg | 🇹🇳Tunisia | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | Mar 2018 |
| HERTRAZ Pdre p.prep.injectable / 150 mg | 🇹🇳Tunisia | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | Mar 2018 |
| HERCEPTIN Pdre p.prep.injectable / 150 mg | 🇹🇳Tunisia | Roche Pharma (Schweiz) AG | expired | Apr 2008 |
| HERCEPTIN SC 600 mg | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| HERCEPTIN 21 mg/ml IV | 🇿🇦South Africa | Roche Products (Pty) Ltd | active | Jan 1900 |
| Hertuzu 150 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| Hertuzu 440 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| Herzuma 150 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| Herzuma 440 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| Trastmab 440 Lyophilized powder for reconstitution | 🇹🇿Tanzania | Intas Pharmaceuticals Ltd | active | — |
| TRASTUZUMAB PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | F. HOFFMANN LA- ROCHE | active | — |
| TRASTUZUMAB PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | MYLAN PHARMACEUTICA LS PRIVATE LIMITED, INDIA | active | — |
| canhera Powder for Injection | 🇹🇿Tanzania | Biocon Biologics UK Limited | active | — |
| canhera Powder for solution for injection | 🇹🇿Tanzania | Biocon Biologics UK Limited | active | — |
| HERCEPTIN POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 150mg Powder for concentrate for solution for infusion | 🌍WW | Celltrion Inc. | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 420mg Powder for concentrate for solution for infusion | 🌍WW | Celltrion Inc. | active | — |
| herceptin SC Injection | 🇹🇿Tanzania | F.Hoffmann-La Roche Limited | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 150 mg Powder for concentrate for solution for infusion | 🌍WW | Samsung Bioepis NL B.V. | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 150mg Powder for concentrate for solution for infusion | 🌍WW | Biocon Biologics Limited | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 420mg Powder for concentrate for solution for infusion | 🌍WW | Biocon Biologics Limited | active | — |
| Trastuzumab Powder for concentrate for solution for infusion 420mg Powder for concentrate for solution for infusion | 🌍WW | Biosimilar Collaborations Ireland Limited | active | — |
| TRASTUZUMAB PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | BIOSIMILARS NEWCO LIMITED | active | — |
| HERTRAZ poudre et solvant pour solution injectable / 300 mg | 🇸🇳Senegal | MYLAN PHARMACEUTICAL PRIVATE LIMITED | active | — |
Showing 50 of 62 registrations. Sign up free to search and export all.
TRASTUZUMAB in Africa — Regulatory Overview
TRASTUZUMAB is registered across 14 African markets with 62 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, South Africa, WW, Uganda and 10 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 62 registrations, 56 (90%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.